Get the Stockscreener App
23.87
3.98%
-0.99
After Hours:
23.95
0.08
+0.34%
Overview
News
Price History
Option Chain
Financials
Why PFE Down?
Discussions
Forecast
Stock Split
Dividend History
Pfizer Inc stock is traded at $23.87, with a volume of 81.11M.
It is down -3.98% in the last 24 hours and down -3.16% over the past month.
Pfizer is one of the world's largest pharmaceutical firms, with annual sales of roughly $60 billion. While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, and cardiovascular treatment Eliquis. Pfizer sells these products globally, with international sales representing 40% of total sales. Within international sales, emerging markets are a major contributor.
See More
Previous Close:
$24.86
Open:
$24.81
24h Volume:
81.11M
Relative Volume:
1.99
Market Cap:
$135.71B
Revenue:
$63.83B
Net Income/Loss:
$10.77B
P/E Ratio:
12.70
EPS:
1.88
Net Cash Flow:
$12.44B
1W Performance:
-4.06%
1M Performance:
-3.16%
6M Performance:
-7.16%
1Y Performance:
-18.14%
1-Day Range:
$23.84
$24.84
1-Week Range:
$23.84
$24.96
52-Week Range:
$20.91
$30.43
Pfizer Inc Stock (PFE) Company Profile
Name
Pfizer Inc
Sector
Industry
Phone
(212) 733-2323
Address
66 HUDSON BOULEVARD EAST, NEW YORK, NY
Compare PFE with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PFE
Pfizer Inc
|
23.87 | 139.69B | 63.83B | 10.77B | 12.44B | 1.88 |
|
LLY
Lilly Eli Co
|
755.39 | 676.48B | 53.26B | 13.80B | -50.20M | 15.30 |
|
JNJ
Johnson Johnson
|
178.06 | 423.36B | 90.62B | 22.66B | 18.18B | 9.35 |
|
ABBV
Abbvie Inc
|
218.34 | 373.87B | 58.33B | 3.73B | 18.24B | 2.10 |
|
NVS
Novartis Ag Adr
|
124.12 | 244.98B | 53.40B | 13.68B | 16.89B | 6.9231 |
|
MRK
Merck Co Inc
|
82.81 | 209.89B | 63.43B | 16.42B | 14.72B | 6.49 |
Pfizer Inc Stock (PFE) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-22-25 | Initiated | Cantor Fitzgerald | Neutral |
| Dec-10-24 | Resumed | BofA Securities | Neutral |
| Nov-15-24 | Initiated | Wolfe Research | Underperform |
| Oct-25-24 | Resumed | Citigroup | Neutral |
| Oct-17-24 | Initiated | Bernstein | Mkt Perform |
| Aug-07-24 | Upgrade | Daiwa Securities | Neutral → Outperform |
| Mar-22-24 | Downgrade | Argus | Buy → Hold |
| Feb-23-24 | Initiated | Guggenheim | Buy |
| Jan-04-24 | Downgrade | TD Cowen | Outperform → Market Perform |
| Oct-20-23 | Resumed | UBS | Neutral |
| Oct-16-23 | Upgrade | Jefferies | Hold → Buy |
| Jul-17-23 | Reiterated | JP Morgan | Neutral |
| Jul-14-23 | Initiated | HSBC Securities | Buy |
| Jun-29-23 | Downgrade | Credit Suisse | Outperform → Neutral |
| May-11-23 | Downgrade | Daiwa Securities | Outperform → Neutral |
| Mar-06-23 | Initiated | Jefferies | Hold |
| Feb-07-23 | Upgrade | Daiwa Securities | Neutral → Outperform |
| Jan-26-23 | Downgrade | UBS | Buy → Neutral |
| Jan-17-23 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jan-04-23 | Downgrade | BofA Securities | Buy → Neutral |
| Dec-13-22 | Upgrade | Goldman | Neutral → Buy |
| Nov-18-22 | Initiated | Credit Suisse | Outperform |
| May-23-22 | Initiated | SVB Leerink | Mkt Perform |
| Apr-06-22 | Resumed | Morgan Stanley | Equal-Weight |
| Jan-05-22 | Upgrade | BofA Securities | Neutral → Buy |
| Jan-03-22 | Reiterated | Bernstein | Mkt Perform |
| Dec-20-21 | Reiterated | Cowen | Outperform |
| Dec-17-21 | Initiated | Goldman | Neutral |
| Dec-13-21 | Upgrade | UBS | Neutral → Buy |
| Dec-09-21 | Initiated | Wells Fargo | Overweight |
| Nov-19-21 | Initiated | BMO Capital Markets | Outperform |
| Jul-27-21 | Resumed | Truist | Buy |
| May-06-21 | Downgrade | Mizuho | Buy → Neutral |
| Apr-07-21 | Resumed | RBC Capital Mkts | Sector Perform |
| Feb-04-21 | Upgrade | DZ Bank | Hold → Buy |
| Dec-16-20 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Nov-19-20 | Resumed | Goldman | Neutral |
| Nov-10-20 | Resumed | Bernstein | Mkt Perform |
| Oct-12-20 | Downgrade | Atlantic Equities | Overweight → Neutral |
| Sep-29-20 | Initiated | Berenberg | Hold |
| Jun-16-20 | Initiated | SVB Leerink | Mkt Perform |
| Feb-27-20 | Initiated | Barclays | Equal Weight |
| Feb-27-20 | Upgrade | Standpoint Research | Hold → Buy |
| Feb-06-20 | Initiated | Mizuho | Buy |
| Jan-07-20 | Initiated | RBC Capital Mkts | Outperform |
| Oct-17-19 | Resumed | BofA/Merrill | Neutral |
| Jul-30-19 | Downgrade | BofA/Merrill | Buy → Neutral |
| Jul-30-19 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jun-04-19 | Resumed | Morgan Stanley | Overweight |
| Feb-20-19 | Resumed | Citigroup | Neutral |
| Jan-31-19 | Upgrade | Argus | Hold → Buy |
| Jan-31-19 | Upgrade | Credit Suisse | Neutral → Outperform |
| Jan-23-19 | Downgrade | UBS | Buy → Neutral |
| Dec-11-18 | Downgrade | JP Morgan | Overweight → Neutral |
| Nov-01-18 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
View All
Pfizer Inc Stock (PFE) Latest News
Great Lakes Advisors LLC Raises Stake in Pfizer Inc. $PFE - MarketBeat
Pfizer Inc. $PFE Shares Sold by UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC - MarketBeat
Fred Alger Management LLC Purchases 14,768 Shares of Pfizer Inc. $PFE - MarketBeat
Logan Capital Management Inc. Buys 76,174 Shares of Pfizer Inc. $PFE - MarketBeat
Empowered Funds LLC Sells 248,165 Shares of Pfizer Inc. $PFE - MarketBeat
Pfizer (PFE) Shares Dip Amid Vaccine Controversy - GuruFocus
Why BioNTech Stock Sank by More Than 7% Today - The Motley Fool
Pfizer, Moderna shares plunge on report that Trump officials plan to link 25 child deaths to COVID vaccine - New York Post
Why Pfizer (PFE) Shares Are Sliding Today - Yahoo Finance
Pfizer, Moderna, BioNTech Stocks Tumble After Report Of Plan To Link COVID Vaccines To Child Deaths - Benzinga
Pfizer Faces Legal Battle Over Paxlovid - timothysykes.com
Moderna, Pfizer stocks fall as Trump officials reportedly link COVID shots to child deaths - MarketWatch
Trump officials to link child deaths to COVID shots, Washington Post reports - Reuters
Moderna, Pfizer dip after WaPo reports Trump officials’ plan to link Covid vaccines to child deaths - Sherwood News
BridgeBio (BBIO) Challenges Pfizer's ATTR-CM Promotion Tactics - GuruFocus
Pfizer's Late-Stage Pipeline Fuels Long-Term Growth Prospects - Yahoo Finance
Pfizer, Alnylam earn BridgeBio ire over sales tactics for amyloidosis drugs: Bloomberg - Seeking Alpha
Anson Funds Management LP Sells 30,000 Shares of Pfizer Inc. $PFE - MarketBeat
Strs Ohio Makes New Investment in Pfizer Inc. $PFE - MarketBeat
Birmingham Capital Management Co. Inc. AL Has $4.14 Million Stake in Pfizer Inc. $PFE - MarketBeat
Pfizer Inc. $PFE Shares Purchased by Intrua Financial LLC - MarketBeat
Advisors Capital Management LLC Has $38.75 Million Stock Position in Pfizer Inc. $PFE - MarketBeat
Mattson Financial Services LLC Has $2.57 Million Holdings in Pfizer Inc. $PFE - MarketBeat
How Pfizer Inc. (PFE) Affects Rotational Strategy Timing - news.stocktradersdaily.com
WBI Investments LLC Lowers Stock Position in Pfizer Inc. $PFE - MarketBeat
MBL Wealth LLC Takes Position in Pfizer Inc. $PFE - MarketBeat
Pfizer Inc. $PFE Position Boosted by Focus Partners Wealth - MarketBeat
Integrity Alliance LLC. Grows Position in Pfizer Inc. $PFE - MarketBeat
SCS Capital Management LLC Takes Position in Pfizer Inc. $PFE - MarketBeat
12,098 Shares in Pfizer Inc. $PFE Bought by MBB Public Markets I LLC - MarketBeat
Jones Financial Companies Lllp Cuts Stock Holdings in Pfizer Inc. $PFE - MarketBeat
Pfizer Is Growing More Reliant on Vaccines as Controversies Swirl - Barron's
Why Pfizer (PFE) Outpaced the Stock Market Today - Yahoo Finance
Pfizer’s Comeback Accelerates (NYSE:PFE) - Seeking Alpha
Pfizer, other drugmakers ask court to bar ex-prosecutor from price-fixing lawsuits - Reuters
BridgeBio Says Pfizer, Alnylam Aren’t Playing Fair in Blockbuster Race - Bloomberg.com
Pfizer (PFE) and Greenstone Face US$71 Million Settlement in Antitrust Lawsuit - simplywall.st
Pfizer (PFE) and BioNTech SE Announce Positive Topline Results From an Ongoing Phase 3 Clinical Trial - Yahoo Finance
Pfizer (PFE), Astellas Post Favorable Trial Results for Bladder Cancer Combo - Yahoo Finance
Westbourne Investments Inc. Buys Shares of 95,165 Pfizer Inc. $PFE - MarketBeat
USA Vaccine Market Outlook Report 2025-2030 | Pfizer, Moderna, J&J, Merck, and GSK Compete Through Innovation, Approvals, and Strategic PartnershipsResearchAndMarkets.com - Business Wire
Bluefin Capital Management LLC Invests $441,000 in Pfizer Inc. $PFE - MarketBeat
Blue Rock Wealth Management LLC Makes New $325,000 Investment in Pfizer Inc. $PFE - MarketBeat
Belpointe Asset Management LLC Reduces Holdings in Pfizer Inc. $PFE - MarketBeat
Jupiter Wealth Management LLC Has $826,000 Stake in Pfizer Inc. $PFE - MarketBeat
21,133 Shares in Pfizer Inc. $PFE Bought by Ransom Advisory Ltd - MarketBeat
Plato Investment Management Ltd Sells 17,407 Shares of Pfizer Inc. $PFE - MarketBeat
Woodline Partners LP Trims Position in Pfizer Inc. $PFE - MarketBeat
Zacks Industry Outlook Highlights Eli Lilly, Johnson & Johnson, Novartis, Pfizer and Bayer - Yahoo Finance
Integrated Wealth Concepts LLC Sells 10,984 Shares of Pfizer Inc. $PFE - MarketBeat
Arbutus Biopharma’s Patent Ruling in Pfizer Lawsuit - TipRanks
Pfizer Inc Stock (PFE) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.81%
1.05%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):